About the Project
PRECISE will provide policy makers with insight into the trade-offs that need to be made when deciding on reimbursement for targeted interventions based on uncertain evidence. PRECISE will develop new methods which will draw on existing principles to deal with uncertainty and heterogeneity in the economic evaluation of personalised medicine. Multiple real case studies will be developed to demonstrate the value of the methods for informing reimbursement decisions for new health technologies.
Sub-projects
Workpage 1 (University of Oslo): Benefits and costs of early access to new health technologies when evidence is immature.
Workpage 2 (Linköping University): Right treatment to the right patient with the right evaluation methods and research portifolio.
Workpage 3 (University of Oslo): Recommendations for improving guidelines, such as national pharmaeconomic guidelines for reimbursement applications.
Financing
Nordforsk (Biotek2021) - Innovations in Personalised Medicine: Towards Implementation of Personalised Medicine in Health Care
Cooporation
Norwegian Institute of Public Health
Department of Medical and Health Sciences, Linköping University
School of Health and Related Research (ScHARR), University of Sheffield
Centre for Health Economics, University of York
Population Health Sciences, University of Bristol
Start - Finish
May 2019 to May 2023